Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
Molecular Psychiatry2010Vol. 16(3), pp. 321–332
Citations Over TimeTop 1% of 2010 papers
Daniel E. Adkins, Karolina A. Åberg, Joseph L. McClay, József Bukszár, Zhongming Zhao, Peilin Jia, T. Scott Stroup, Diana O. Perkins, Joseph P. McEvoy, Jeffrey A. Lieberman, Patrick F. Sullivan, Edwin J. C. G. van den Oord
Related Papers
- Comparison between the Clinical Effects of Olanzapine and Risperidone in Treatment of Alzheimer Patients with Behavioral and Psychological Symptoms(2013)
- → Cost Evaluation of Risperidone Compared With Olanzapine(2003)13 cited
- The effects of risperidone and olanzapine on the indications for clozapine.(1998)
- → RISPERIDONE AND OLANZAPNE IN-PATIENT UTILIZATION IN THE UNIVERSITY OF MALAYA MEDICAL CENTRE, KUALA LUMPUR(2006)
- Cost effectiveness analysis of olanzapine and risperidone(2009)